Cardiovascular Revascularization Medicine最新文献

英文中文

Editorial: Chronic total occlusion and survival: The never-ending debate 社论：慢性全闭塞和生存：永无止境的争论。

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiovascular Revascularization Medicine

Pub Date : 2025-12-01 DOI: 10.1016/j.carrev.2025.08.006

Sant Kumar , Lorenzo Azzalini

引用次数: 0

Disparities in access, utilization, and outcomes of percutaneous coronary intervention in Hispanics compared to non-Hispanic Whites in the United States: A comprehensive review 与非西班牙裔美国白人相比，西班牙裔美国人在经皮冠状动脉介入治疗的可及性、使用率和结果方面的差异：一项全面的综述。

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiovascular Revascularization Medicine

Pub Date : 2025-12-01 DOI: 10.1016/j.carrev.2025.09.008

Eric C.H. Leung , James C. Blankenship , Carolina Ponce Orellana , Deirdre Hill , Bharath Yarlagadda

Background

Ischemic heart disease is the leading cause of cardiovascular mortality in the United States, with percutaneous coronary intervention (PCI) being one of the definitive treatments. Historically, data suggested Hispanics, when compared to non-Hispanic Whites, suffer worse acute coronary syndrome mortality rates. Therefore, we conducted a comprehensive literature review to summarize factors influencing PCI outcomes in this population.

Methods

In accordance with PRISMA guidelines for systematic reviews, we performed a literature search encompassing PCI for any indication with Hispanic-specific outcomes using the PubMed database through April 2025 yielding 69 studies. Authors independently screened search results and resolved discrepancies through consensus. Meta-analysis was performed where ever feasible using random effects models due to expected study heterogeneity.

Results/data

Hispanics experience acute myocardial infarction more frequently and are more likely to present urgently or emergently than Whites. Hispanic ethnicity correlates with delayed door-to-balloon and catheterization laboratory activation times. Additionally, Hispanics are disproportionately admitted to low procedure volume hospitals with disparities in hospital quality resulting in inferior PCI outcomes. High Medicaid and uninsured rates in Hispanics reflect cost-prohibitive healthcare access limitations, resulting in a trend towards lower rates of resvascularization and procedural differences like stent utilization. However, in-hospital and long-term outcomes between Hispanic and White populations undergoing PCI are similar.

Conclusion(s)

This review uncovers an incongruity between profound disparities in access and utilization of PCI, driven by socio-economic determinants, and comparable in-hospital and mortality outcomes between Hispanics and Whites. Consequently, it highlights the need for increased research to improve patient outcomes and reduce health disparities.

背景：缺血性心脏病是美国心血管疾病死亡的主要原因，经皮冠状动脉介入治疗（PCI）是明确的治疗方法之一。历史上的数据表明，与非西班牙裔白人相比，西班牙裔人患急性冠状动脉综合征的死亡率更高。因此，我们进行了全面的文献综述，总结影响该人群PCI预后的因素。方法：根据PRISMA系统评价指南，我们使用PubMed数据库进行文献检索，检索到截至2025年4月的69项研究，包括PCI治疗的任何适应症和西班牙裔特定结果。作者独立筛选搜索结果，并通过共识解决差异。由于预期的研究异质性，在可行的情况下使用随机效应模型进行meta分析。结果/数据：与白人相比，西班牙裔更频繁地经历急性心肌梗死，更有可能出现紧急或紧急情况。西班牙裔与延迟门到球囊和导管实验室激活时间相关。此外，由于医院质量的差异导致PCI治疗结果较差，西班牙裔患者被不成比例地送入低手术量的医院。西班牙裔的高医疗补助率和未参保率反映了昂贵的医疗保健准入限制，导致了血管重建术和支架使用等手术差异率降低的趋势。然而，西班牙裔和白人接受PCI的住院和长期结果是相似的。结论：本综述揭示了由社会经济决定因素驱动的PCI获取和利用的深刻差异与西班牙裔和白人之间可比较的住院和死亡率结果之间的不一致。因此，它强调需要加强研究，以改善患者的治疗结果和减少健康差距。

{"title":"Disparities in access, utilization, and outcomes of percutaneous coronary intervention in Hispanics compared to non-Hispanic Whites in the United States: A comprehensive review","authors":"Eric C.H. Leung , James C. Blankenship , Carolina Ponce Orellana , Deirdre Hill , Bharath Yarlagadda","doi":"10.1016/j.carrev.2025.09.008","DOIUrl":"10.1016/j.carrev.2025.09.008","url":null,"abstract":"<div><h3>Background</h3><div>Ischemic heart disease is the leading cause of cardiovascular mortality in the United States, with percutaneous coronary intervention (PCI) being one of the definitive treatments. Historically, data suggested Hispanics, when compared to non-Hispanic Whites, suffer worse acute coronary syndrome mortality rates. Therefore, we conducted a comprehensive literature review to summarize factors influencing PCI outcomes in this population.</div></div><div><h3>Methods</h3><div>In accordance with PRISMA guidelines for systematic reviews, we performed a literature search encompassing PCI for any indication with Hispanic-specific outcomes using the PubMed database through April 2025 yielding 69 studies. Authors independently screened search results and resolved discrepancies through consensus. Meta-analysis was performed where ever feasible using random effects models due to expected study heterogeneity.</div></div><div><h3>Results/data</h3><div>Hispanics experience acute myocardial infarction more frequently and are more likely to present urgently or emergently than Whites. Hispanic ethnicity correlates with delayed door-to-balloon and catheterization laboratory activation times. Additionally, Hispanics are disproportionately admitted to low procedure volume hospitals with disparities in hospital quality resulting in inferior PCI outcomes. High Medicaid and uninsured rates in Hispanics reflect cost-prohibitive healthcare access limitations, resulting in a trend towards lower rates of resvascularization and procedural differences like stent utilization. However, in-hospital and long-term outcomes between Hispanic and White populations undergoing PCI are similar.</div></div><div><h3>Conclusion(s)</h3><div>This review uncovers an incongruity between profound disparities in access and utilization of PCI, driven by socio-economic determinants, and comparable in-hospital and mortality outcomes between Hispanics and Whites. Consequently, it highlights the need for increased research to improve patient outcomes and reduce health disparities.</div></div>","PeriodicalId":47657,"journal":{"name":"Cardiovascular Revascularization Medicine","volume":"81 ","pages":"Pages 144-153"},"PeriodicalIF":1.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145226196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Comparison of drug-coated versus conventional balloons for the side branch of the bifurcation lesion - multicenter randomized controlled study - (OCVC-BIF): Design and rationale 多中心随机对照研究（OCVC-BIF）：设计和基本原理：药物包被与常规球囊在分岔病变侧支中的比较

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiovascular Revascularization Medicine

Pub Date : 2025-12-01 DOI: 10.1016/j.carrev.2025.03.024

Tomoharu Dohi , Takayuki Ishihara , Hirota Kida , Daisuke Nakamura , Atsushi Kikuchi , Tsutomu Kawai , Naoki Mori , Naotaka Okamoto , Yasunori Ueda , Ryu Shutta , Minoru Ichikawa , Toshiaki Mano , Tetsuya Watanabe , Yoshiharu Higuchi , Masami Nishino , Eisuke Hida , Tomoharu Sato , Shungo Hikoso , Daisaku Nakatani , Yohei Sotomi , Yasushi Sakata

Background

Although several clinical trials have suggested the usefulness of drug-coated balloons (DCB) for side-branch lesions, their efficacy and safety have not yet been established.

Methods and study design

The Osaka Cardiovascular Conference (OCVC) will conduct a multicenter, randomized, open-label, controlled trial aiming to examine whether additional DCB treatment for the side branch after main vessel stenting followed by kissing balloon inflation (KBI) is superior to only KBI by conventional balloons in PCI patients with coronary bifurcation lesions. The primary endpoint is restenosis of side branches documented by scheduled or symptom-driven coronary angiography during 9-month follow-up period after the index PCI. The key secondary endpoints include major adverse cardiac event which consists of cardiac death, myocardial infarction, target lesion revascularization, and stent thrombosis, and optical coherence tomography findings. A total of 300 patients will be enrolled and followed up to 1 year.

Summary

The OCVC-BIF trial is a randomized controlled trial designed to assess whether additional DCB treatment for side branch is superior to only KBI by conventional balloons in patients with coronary bifurcation lesions undergoing PCI with main vessel stenting.

背景：虽然一些临床试验表明药物包被球囊（DCB）治疗侧分支病变的有效性，但其有效性和安全性尚未确定。方法和研究设计：大阪心血管会议（OCVC）将开展一项多中心、随机、开放标签、对照试验，旨在研究在主血管支架植入术后对侧支进行额外的DCB治疗，然后进行亲吻球囊充气（KBI），是否优于仅通过传统球囊进行KBI的PCI患者冠状动脉分叉病变。主要终点是在PCI术后9个月的随访期间，通过定期或症状驱动的冠状动脉造影记录的侧支再狭窄。主要次要终点包括主要心脏不良事件，包括心源性死亡、心肌梗死、靶病变血运重建术和支架血栓形成，以及光学相干断层扫描结果。共纳入300例患者，随访1年。摘要：OCVC-BIF试验是一项随机对照试验，旨在评估在接受PCI合并主血管支架植入术的冠状动脉分叉病变患者中，对侧支进行额外DCB治疗是否优于仅通过常规球囊进行KBI。

{"title":"Comparison of drug-coated versus conventional balloons for the side branch of the bifurcation lesion - multicenter randomized controlled study - (OCVC-BIF): Design and rationale","authors":"Tomoharu Dohi , Takayuki Ishihara , Hirota Kida , Daisuke Nakamura , Atsushi Kikuchi , Tsutomu Kawai , Naoki Mori , Naotaka Okamoto , Yasunori Ueda , Ryu Shutta , Minoru Ichikawa , Toshiaki Mano , Tetsuya Watanabe , Yoshiharu Higuchi , Masami Nishino , Eisuke Hida , Tomoharu Sato , Shungo Hikoso , Daisaku Nakatani , Yohei Sotomi , Yasushi Sakata","doi":"10.1016/j.carrev.2025.03.024","DOIUrl":"10.1016/j.carrev.2025.03.024","url":null,"abstract":"<div><h3>Background</h3><div>Although several clinical trials have suggested the usefulness of drug-coated balloons (DCB) for side-branch lesions, their efficacy and safety have not yet been established.</div></div><div><h3>Methods and study design</h3><div>The Osaka Cardiovascular Conference (OCVC) will conduct a multicenter, randomized, open-label, controlled trial aiming to examine whether additional DCB treatment for the side branch after main vessel stenting followed by kissing balloon inflation (KBI) is superior to only KBI by conventional balloons in PCI patients with coronary bifurcation lesions. The primary endpoint is restenosis of side branches documented by scheduled or symptom-driven coronary angiography during 9-month follow-up period after the index PCI. The key secondary endpoints include major adverse cardiac event which consists of cardiac death, myocardial infarction, target lesion revascularization, and stent thrombosis, and optical coherence tomography findings. A total of 300 patients will be enrolled and followed up to 1 year.</div></div><div><h3>Summary</h3><div>The OCVC-BIF trial is a randomized controlled trial designed to assess whether additional DCB treatment for side branch is superior to only KBI by conventional balloons in patients with coronary bifurcation lesions undergoing PCI with main vessel stenting.</div></div>","PeriodicalId":47657,"journal":{"name":"Cardiovascular Revascularization Medicine","volume":"81 ","pages":"Pages 57-61"},"PeriodicalIF":1.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143788932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Association between pathophysiological coronary artery disease patterns and perivascular adipose tissue density 病理生理冠状动脉疾病模式与血管周围脂肪组织密度之间的关系。

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiovascular Revascularization Medicine

Pub Date : 2025-12-01 DOI: 10.1016/j.carrev.2025.05.026

Chieh Yang Koo , Carlos Collet , Kazumasa Ikeda , Daniel Munhoz , Frédéric Bouisset , Jeroen Sonck , Toshiro Shinke , Hirohiko Ando , Brian Ko , Evald Høj Christiansen , Thomas Engstrøm , Fernando Rivero , Antonio Maria Leone , Simone Biscaglia , Andy Yong , Ashkan Eftekhari , Stephane Fournier , Masafumi Nakayama , Lokien X. van Nunen , Liyew Desta , Takuya Mizukami

引用次数: 0

Acoustic-based systems for the evaluation of coronary artery disease: A systematic literature review 基于声学的冠状动脉疾病评估系统：系统的文献综述。

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiovascular Revascularization Medicine

Pub Date : 2025-12-01 DOI: 10.1016/j.carrev.2025.07.008

Serge Korjian , George S. Chrysant , Suzanne J. Baron

Background

Coronary artery disease (CAD) remains one of the primary causes of morbidity and mortality worldwide. Acoustic-based systems offer the prospect of a rapid, noninvasive method to diagnose and stratify risk in patients with suspected CAD.

Methods

We conducted a systematic review to assess the diagnostic accuracy, cost-effectiveness, and feasibility of acoustic-based systems for CAD risk stratification and diagnosis. Eligible studies published from 1980 to 2025 were retrieved from MEDLINE, Embase, and ClinicalTrials.gov. We included articles that compared acoustic-based systems to standard-of-care non-acoustic tools for CAD diagnosis, such as invasive angiography or coronary computed tomography angiography. Data on sensitivity, specificity, negative predictive value, positive predictive value, cost, and outcomes were extracted.

Results

We identified 32 studies examining a range of acoustic-based systems, including digital stethoscopes and advanced acoustic cardiographs. Most systems demonstrated high sensitivity and strong negative predictive values, suggesting they can serve as reliable rule-out tools for CAD. Preliminary cost analyses suggest that acoustic-based systems could reduce unnecessary imaging and lower resource use, particularly for low- to intermediate-risk patients. Limited evidence also points to a possible role in prognostication when acoustic scores are combined with clinical data.

Conclusions

Acoustic-based systems appear promising as non-invasive, rapid, and potentially cost-effective methods for diagnosing and stratifying risk in patients with suspected CAD. Further large-scale research is necessary to refine these technologies, improve implementation, and evaluate clinical outcomes across diverse populations.

背景：冠状动脉疾病（CAD）仍然是世界范围内发病率和死亡率的主要原因之一。声学系统为疑似CAD患者提供了一种快速、无创的诊断和风险分层方法。方法：我们进行了一项系统综述，以评估声学系统对CAD风险分层和诊断的诊断准确性、成本效益和可行性。从MEDLINE、Embase和ClinicalTrials.gov检索1980年至2025年发表的符合条件的研究。我们收录了一些文章，将声学系统与CAD诊断的标准护理非声学工具（如侵入性血管造影或冠状动脉计算机断层扫描血管造影）进行了比较。提取敏感性、特异性、阴性预测值、阳性预测值、成本和结果的数据。结果：我们确定了32项研究，检查了一系列基于声学的系统，包括数字听诊器和先进的声学心动图。大多数系统显示出高灵敏度和强阴性预测值，表明它们可以作为CAD的可靠排除工具。初步的成本分析表明，基于声学的系统可以减少不必要的成像和更低的资源使用，特别是对中低风险患者。有限的证据也指出，当声学评分与临床数据相结合时，可能在预后中起作用。结论：声学系统是非侵入性的、快速的、具有潜在成本效益的方法，可用于疑似CAD患者的诊断和风险分层。进一步的大规模研究是必要的，以完善这些技术，改进实施，并评估不同人群的临床结果。

{"title":"Acoustic-based systems for the evaluation of coronary artery disease: A systematic literature review","authors":"Serge Korjian , George S. Chrysant , Suzanne J. Baron","doi":"10.1016/j.carrev.2025.07.008","DOIUrl":"10.1016/j.carrev.2025.07.008","url":null,"abstract":"<div><h3>Background</h3><div>Coronary artery disease (CAD) remains one of the primary causes of morbidity and mortality worldwide. Acoustic-based systems offer the prospect of a rapid, noninvasive method to diagnose and stratify risk in patients with suspected CAD.</div></div><div><h3>Methods</h3><div>We conducted a systematic review to assess the diagnostic accuracy, cost-effectiveness, and feasibility of acoustic-based systems for CAD risk stratification and diagnosis. Eligible studies published from 1980 to 2025 were retrieved from MEDLINE, Embase, and <span><span>ClinicalTrials.gov</span><svg><path></path></svg></span>. We included articles that compared acoustic-based systems to standard-of-care non-acoustic tools for CAD diagnosis, such as invasive angiography or coronary computed tomography angiography. Data on sensitivity, specificity, negative predictive value, positive predictive value, cost, and outcomes were extracted.</div></div><div><h3>Results</h3><div>We identified 32 studies examining a range of acoustic-based systems, including digital stethoscopes and advanced acoustic cardiographs. Most systems demonstrated high sensitivity and strong negative predictive values, suggesting they can serve as reliable rule-out tools for CAD. Preliminary cost analyses suggest that acoustic-based systems could reduce unnecessary imaging and lower resource use, particularly for low- to intermediate-risk patients. Limited evidence also points to a possible role in prognostication when acoustic scores are combined with clinical data.</div></div><div><h3>Conclusions</h3><div>Acoustic-based systems appear promising as non-invasive, rapid, and potentially cost-effective methods for diagnosing and stratifying risk in patients with suspected CAD. Further large-scale research is necessary to refine these technologies, improve implementation, and evaluate clinical outcomes across diverse populations.</div></div>","PeriodicalId":47657,"journal":{"name":"Cardiovascular Revascularization Medicine","volume":"81 ","pages":"Pages 137-143"},"PeriodicalIF":1.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144700095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Artificial intelligence-driven techniques for interventional cardiology: A current appraisal 介入心脏病学的人工智能驱动技术：当前评价。

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiovascular Revascularization Medicine

Pub Date : 2025-12-01 DOI: 10.1016/j.carrev.2025.06.016

Debabrata Dash , Umanshi Dash , Batool Abu-Dakka

The ability to simulate the process of human intelligence with computer systems is known as artificial intelligence (AI). This review aims to elucidate the impact of AI on clinical practice in interventional cardiology (IC) with particular attention to its most recent developments. In recent years, there have been exceptional breakthroughs in computational tools, particularly in the development of AI. The main objectives are to achieve the integration of various cardiac imaging modalities, establish online decision support systems and platforms based on augmented and/or virtual realities, and finally to create automatic medical systems, facilitating access to electronic health data about patients. In summary, AI applications in IC can be categorized into two primary domains: virtual and physical. As a result, numerous studies have offered information on the use of AI for automated interpretation and analysis of data from different cardiac modalities, including electrocardiogram, echocardiography, angiography, cardiac magnetic resonance imaging, and computed tomography as well as data collected during robotic-assisted percutaneous coronary intervention (PCI) procedures.

用计算机系统模拟人类智能过程的能力被称为人工智能（AI）。本文旨在阐明人工智能对介入心脏病学（IC）临床实践的影响，并特别关注其最新发展。近年来，计算工具，特别是人工智能的发展取得了非凡的突破。主要目标是实现各种心脏成像模式的集成，建立基于增强现实和/或虚拟现实的在线决策支持系统和平台，最终创建自动化医疗系统，促进患者电子健康数据的访问。综上所述，集成电路中的人工智能应用可分为两个主要领域：虚拟和物理。因此，许多研究提供了关于使用人工智能自动解释和分析来自不同心脏模式的数据的信息，包括心电图、超声心动图、血管造影、心脏磁共振成像和计算机断层扫描，以及机器人辅助经皮冠状动脉介入治疗（PCI）过程中收集的数据。

{"title":"Artificial intelligence-driven techniques for interventional cardiology: A current appraisal","authors":"Debabrata Dash , Umanshi Dash , Batool Abu-Dakka","doi":"10.1016/j.carrev.2025.06.016","DOIUrl":"10.1016/j.carrev.2025.06.016","url":null,"abstract":"<div><div><span>The ability to simulate the process of human intelligence with computer systems is known as artificial intelligence (AI). This review aims to elucidate the impact of AI on clinical practice in interventional cardiology<span><span> (IC) with particular attention to its most recent developments. In recent years, there have been exceptional breakthroughs in computational tools, particularly in the development of AI. The main objectives are to achieve the integration of various cardiac imaging modalities, establish online decision support systems and platforms based on augmented and/or virtual realities, and finally to create automatic medical systems, facilitating access to electronic health data about patients. In summary, AI applications in IC can be categorized into two primary domains: virtual and physical. As a result, numerous studies have offered information on the use of AI for automated interpretation and analysis of data from different cardiac modalities, including electrocardiogram, </span>echocardiography<span>, angiography, </span></span></span>cardiac magnetic resonance imaging<span>, and computed tomography as well as data collected during robotic-assisted percutaneous coronary intervention (PCI) procedures.</span></div></div>","PeriodicalId":47657,"journal":{"name":"Cardiovascular Revascularization Medicine","volume":"81 ","pages":"Pages 154-163"},"PeriodicalIF":1.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144486629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Evaluation of mid vs distal left anterior descending artery measures in coronary physiology assessment 左前降支中、远端测量在冠状动脉生理学评价中的价值

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiovascular Revascularization Medicine

Pub Date : 2025-12-01 DOI: 10.1016/j.carrev.2024.12.018

Fazal Dalal , Yissela Escobedo , Jose Emilio Exaire , Timothy A. Mixon , Karim Al-Azizi , Darren Kumar , Srini Potluri , R. Jay Widmer

Background

Angina with no obstructive coronary artery disease (ANOCA) occurs in approximately 40 % of patients who undergo diagnostic coronary angiography for symptoms of angina. Coronary physiology assessment (CPA) is a guideline proven method to assess and diagnose these patients for an effective treatment strategy. There is currently no data regarding optimal wire or sensor position for CPA using bolus coronary thermodilution.

Methods

We reviewed CPA data and baseline demographics in a cohort of patients who underwent CPA for ANOCA. We evaluated coronary flow reserve (CFR) and index of microcirculatory resistance (IMR) in patients whereby maximal hyperemia was obtained in the middle portion (4–6 cm) of the left anterior descending artery (LAD) and the distal 2/3 of the LAD using linear regression, Paired t-test, and Bland-Altman analysis.

Results

We assessed 42 patients with a median age of 60.5 [50,67] and 72 % female. Median CFR in the mid-LAD was 3.55 [2.54, 4.58] and 2.71 [2.0,3.88; p = 0.01*] in the distal segment. Median IMR in the mid-LAD was 16.41 mmHg*s [10.60, 22.07] and 22.27 mmHg*s [14.79,37.0] in the distal segment (p = 0.01*). Average distal pressures (Pd) were 77.14 mmHg in the mid and 75.31 mmHg in the distal LAD (p = 0.57) with differing resting (0.75 s vs 0.97 s, p = 0.01*) and hyperemic (0.25 vs 0.40, p = 0.003*) transit times in the mid vs distal vessel, respectively.

Conclusions

Here we demonstrate that CPA outcomes including CFR and IMR values are dependent upon wire positioning with deeper wire position resulting in lower CFR and higher IMR values.

背景：无阻塞性冠状动脉疾病（ANOCA）的心绞痛发生在约40%接受诊断性冠状动脉造影诊断心绞痛症状的患者中。冠状动脉生理评估（CPA）是一种经过指南验证的评估和诊断这些患者的有效治疗策略的方法。目前还没有关于使用大剂量冠状动脉热稀释CPA的最佳导线或传感器位置的数据。方法：我们回顾了一组因ANOCA接受CPA治疗的患者的CPA数据和基线人口统计数据。我们使用线性回归、配对t检验和Bland-Altman分析评估了在左前降支（LAD）中部（4-6 cm）和远端2/3处充血最多的患者的冠状动脉血流储备（CFR）和微循环阻力指数（IMR）。结果我们评估了42例患者，中位年龄为60.5岁[50,67]，72%为女性。lad中期的中位CFR分别为3.55[2.54,4.58]和2.71 [2.0,3.88]；P = 0.01*]。中位lad IMR为16.41 mmHg*s[10.60, 22.07]，远端IMR为22.27 mmHg*s [14.79,37.0] （p = 0.01*）。中端和远端LAD的平均远端压力（Pd）分别为77.14 mmHg和75.31 mmHg (p = 0.57)，静息时间（0.75 s vs 0.97 s, p = 0.01*）和充血时间（0.25 s vs 0.40, p = 0.003*）在中端和远端血管中分别不同。结论：包括CFR和IMR值在内的CPA结果与导线位置有关，较深的导线位置导致较低的CFR和较高的IMR值。

{"title":"Evaluation of mid vs distal left anterior descending artery measures in coronary physiology assessment","authors":"Fazal Dalal , Yissela Escobedo , Jose Emilio Exaire , Timothy A. Mixon , Karim Al-Azizi , Darren Kumar , Srini Potluri , R. Jay Widmer","doi":"10.1016/j.carrev.2024.12.018","DOIUrl":"10.1016/j.carrev.2024.12.018","url":null,"abstract":"<div><h3>Background</h3><div><span>Angina with no obstructive coronary artery disease (ANOCA) occurs in approximately 40 % of patients who undergo diagnostic </span>coronary angiography<span> for symptoms of angina. Coronary physiology assessment (CPA) is a guideline proven method to assess and diagnose these patients for an effective treatment strategy. There is currently no data regarding optimal wire or sensor position for CPA using bolus coronary thermodilution.</span></div></div><div><h3>Methods</h3><div><span><span>We reviewed CPA data and baseline demographics in a cohort of patients who underwent CPA for ANOCA. We evaluated coronary flow<span> reserve (CFR) and index of microcirculatory resistance (IMR) in patients whereby maximal hyperemia was obtained in the middle portion (4–6 cm) of the left anterior descending artery (LAD) and the distal 2/3 of the LAD using </span></span>linear regression, Paired </span><em>t</em>-test, and Bland-Altman analysis.</div></div><div><h3>Results</h3><div>We assessed 42 patients with a median age of 60.5 [50,67] and 72 % female. Median CFR in the mid-LAD was 3.55 [2.54, 4.58] and 2.71 [2.0,3.88; <em>p</em> = 0.01*] in the distal segment<strong>.</strong> Median IMR in the mid-LAD was 16.41 mmHg*s [10.60, 22.07] and 22.27 mmHg*s [14.79,37.0] in the distal segment (<em>p</em> = 0.01*). Average distal pressures (Pd) were 77.14 mmHg in the mid and 75.31 mmHg in the distal LAD (<em>p</em> = 0.57) with differing resting (0.75 s vs 0.97 s, <em>p</em> = 0.01*) and hyperemic (0.25 vs 0.40, <em>p</em> = 0.003*) transit times in the mid vs distal vessel, respectively.</div></div><div><h3>Conclusions</h3><div>Here we demonstrate that CPA outcomes including CFR and IMR values are dependent upon wire positioning with deeper wire position resulting in lower CFR and higher IMR values.</div></div>","PeriodicalId":47657,"journal":{"name":"Cardiovascular Revascularization Medicine","volume":"81 ","pages":"Pages 1-4"},"PeriodicalIF":1.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145712142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Serial quantitative optical coherence tomography for luminal volume changes following either paclitaxel or sirolimus coated balloon in de novo small coronary artery lesions 连续定量光学相干断层扫描检测新发小冠状动脉病变紫杉醇或西罗莫司包被球囊后腔内容积变化。

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiovascular Revascularization Medicine

Pub Date : 2025-12-01 DOI: 10.1016/j.carrev.2025.03.025

Akihiro Tobe , Patrick Serruys , Kotaro Miyashita , Asahi Oshima , Pruthvi Chenniganahosahalli Revaiah , Tsung-Ying Tsai , Dijkstra Jouke , Scot Garg , Angela McInerney , Yoshinobu Onuma , Faisal Sharif

Background

Drug coated balloons (DCB) are a treatment option for lesions in small coronary arteries, with treatment using paclitaxel coated balloons (PCB) associated with less angiographic late lumen loss than sirolimus coated balloons (SCB).

Methods

This single-center sub-study of the TRANSFORM-I study compared quantitative optical coherence tomography (OCT) data in patients with de novo lesions in small coronary arteries treated with the MagicTouch (SCB) or SeQuent Please Neo (PCB). The relationship between the lumen volume of the treated segment immediately post procedure and at 6-month follow-up was evaluated. Late lumen volume loss (LLVL, mm³) was defined as the post-procedural lumen volume – lumen volume at 6 months.

Results

Serial OCT analysis was performed in 19 patients with 21 lesions (SCB: 9 patients/11 lesions; PCB: 10 patients/10 lesions). There was a significant decrease in lumen volume between post-procedure and 6 months in the SCB group (97.35 ± 71.09 mm³ vs 87.96 ± 61.48 mm³, p = 0.03), but not in the PCB group (69.67 ± 38.24 mm3 vs 71.64 ± 42.22 mm3, p = 0.64). The LLVL was 9.39 ± 12.76 mm³ and − 1.97 ± 12.90 mm³ in the SCB and PCB group, respectively (SCB vs PCB, p = 0.06). A trend for interaction between SCB and PCB was observed in the relationship between dissection volume and LLVL (SCB: LLVL = 1.28 ∗ dissection volume + 7.42, p = 0.37; PCB: LLVL = −2.84 ∗ dissection volume + 4.51, p = 0.12; p for interaction = 0.07).

Conclusion

In de novo lesions of small coronary arteries, treatment with an SCB lead to a significant decrease in lumen volume at 6-months compared to post-procedure, with no significant change observed after treatment with a PCB.

背景：药物涂层球囊（DCB）是治疗冠状动脉小动脉病变的一种选择，与西罗莫司涂层球囊（SCB）相比，使用紫杉醇涂层球囊（PCB）治疗血管造影晚期管腔损失较少：这项 TRANSFORM-I 研究的单中心子研究比较了使用 MagicTouch（SCB）或 SeQuent Please Neo（PCB）治疗小冠状动脉新发病变患者的定量光学相干断层扫描（OCT）数据。评估了术后即刻和随访 6 个月时治疗段管腔容积之间的关系。晚期管腔容积损失（LLVL，mm3）被定义为术后管腔容积-6个月时的管腔容积：对 19 名患者的 21 个病灶（SCB：9 名患者/11 个病灶；PCB：10 名患者/10 个病灶）进行了序列 OCT 分析。SCB 组的管腔容积在手术后至 6 个月期间明显减少（97.35 ± 71.09 mm3 vs 87.96 ± 61.48 mm3，p = 0.03），但 PCB 组没有明显减少（69.67 ± 38.24 mm3 vs 71.64 ± 42.22 mm3，p = 0.64）。SCB 组和 PCB 组的 LLVL 分别为 9.39 ± 12.76 mm3 和 - 1.97 ± 12.90 mm3（SCB vs PCB，p = 0.06）。在夹层容积与 LLVL 的关系中，观察到 SCB 和 PCB 之间存在相互作用的趋势（SCB：LLVL = 1.28 ∗ 夹层容积 + 7.42，p = 0.37；PCB：LLVL = -2.84 ∗ 夹层容积 + 4.51，p = 0.12；相互作用的 p = 0.07）：结论：对于小冠状动脉的新发病变，使用 SCB 治疗后，6 个月后的管腔容积与手术后相比明显减少，而使用 PCB 治疗后则没有观察到明显变化。

{"title":"Serial quantitative optical coherence tomography for luminal volume changes following either paclitaxel or sirolimus coated balloon in de novo small coronary artery lesions","authors":"Akihiro Tobe , Patrick Serruys , Kotaro Miyashita , Asahi Oshima , Pruthvi Chenniganahosahalli Revaiah , Tsung-Ying Tsai , Dijkstra Jouke , Scot Garg , Angela McInerney , Yoshinobu Onuma , Faisal Sharif","doi":"10.1016/j.carrev.2025.03.025","DOIUrl":"10.1016/j.carrev.2025.03.025","url":null,"abstract":"<div><h3>Background</h3><div>Drug coated balloons (DCB) are a treatment option for lesions in small coronary arteries, with treatment using paclitaxel coated balloons (PCB) associated with less angiographic late lumen loss than sirolimus coated balloons (SCB).</div></div><div><h3>Methods</h3><div>This single-center sub-study of the TRANSFORM-I study compared quantitative optical coherence tomography (OCT) data in patients with de novo lesions in small coronary arteries treated with the MagicTouch (SCB) or SeQuent Please Neo (PCB). The relationship between the lumen volume of the treated segment immediately post procedure and at 6-month follow-up was evaluated. Late lumen volume loss (LLVL, mm<sup>3</sup>) was defined as the post-procedural lumen volume – lumen volume at 6 months.</div></div><div><h3>Results</h3><div>Serial OCT analysis was performed in 19 patients with 21 lesions (SCB: 9 patients/11 lesions; PCB: 10 patients/10 lesions). There was a significant decrease in lumen volume between post-procedure and 6 months in the SCB group (97.35 ± 71.09 mm<sup>3</sup> vs 87.96 ± 61.48 mm<sup>3</sup>, <em>p</em> = 0.03), but not in the PCB group (69.67 ± 38.24 mm3 vs 71.64 ± 42.22 mm3, <em>p</em> = 0.64). The LLVL was 9.39 ± 12.76 mm<sup>3</sup> and − 1.97 ± 12.90 mm<sup>3</sup> in the SCB and PCB group, respectively (SCB vs PCB, <em>p</em> = 0.06). A trend for interaction between SCB and PCB was observed in the relationship between dissection volume and LLVL (SCB: LLVL = 1.28 ∗ dissection volume + 7.42, <em>p</em> = 0.37; PCB: LLVL = −2.84 ∗ dissection volume + 4.51, <em>p</em> = 0.12; p for interaction = 0.07).</div></div><div><h3>Conclusion</h3><div>In de novo lesions of small coronary arteries, treatment with an SCB lead to a significant decrease in lumen volume at 6-months compared to post-procedure, with no significant change observed after treatment with a PCB.</div></div>","PeriodicalId":47657,"journal":{"name":"Cardiovascular Revascularization Medicine","volume":"81 ","pages":"Pages 62-67"},"PeriodicalIF":1.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Editorial: Intravascular imaging during coronary intervention. Why is there still resistance to full adoption? 社论：冠状动脉介入治疗中的血管内成像。为什么对全面采用仍然存在阻力？

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiovascular Revascularization Medicine

Pub Date : 2025-12-01 DOI: 10.1016/j.carrev.2025.06.025

John McB. Hodgson

引用次数: 0

Editorial: Beyond the valve: Racial disparities and structural burdens in infective endocarditis 社论：超越瓣膜：感染性心内膜炎的种族差异和结构负担。

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiovascular Revascularization Medicine

Pub Date : 2025-12-01 DOI: 10.1016/j.carrev.2025.06.033

Vitor Emer Egypto Rosa, Carlos M. Campos

引用次数: 0

首页上一页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Cardiovascular Revascularization Medicine

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀